• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DGL
Click for more information
0.94% $5.36

Delegat Group Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Beverages - Wineries & Distilleries

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DGL
Ann: DGL - 2024 Annual Report 		30/09/24 0 27
30/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  27 
DGL
Ann: DGL - Director Nominations 		06/09/24 0 53
06/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  53 
DGL
Ann: Ongoing Disclosure Notice - Murray Annabell 		06/09/24 0 59
Metals & Mining SECTOR NEWS

Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity

Read More   right-arrow Created with Sketch.
CC9
03 Oct 2024
CHARIOT CORPORATION LTD
06/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  59 
DGL
Ann: DGL: 2024 Final Dividend 		29/08/24 0 60
29/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  60 
DGL
Ann: FY24 Results: Delegat delivers solid earnings 		29/08/24 0 91
29/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  91 
DGL
Ann: DGL - Timing of 2024 Full Year Results Announcement 		07/08/24 0 70
07/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  70 
DGL
Ann: Initial Disclosure Notice - Doug McKay 		01/08/24 0 72
01/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  72 
DGL
Ann: DGL - Appointment of Director 		01/08/24 0 74
01/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  74 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS Significant copper and TREO results from West Arunta Project indicate a substantial multi-million tonne copper resource, with mineralisation starting from surface
right-arrow Created with Sketch.
RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
NEWS Boorara Gold Project hits first ore milestone—$30M in free cashflow forecast, find out what’s driving the success
right-arrow Created with Sketch.
NEWS New multi-lode gold shoot discovery boosts development potential—find out who's behind this
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
(20min delay)
Last
$5.36 		Change
0.050(0.94%) 		Mkt cap ! n/a
Open High Low Value Volume
$5.38 $5.38 $5.36 $5.446K 1.016K

Buyers (Bids)

No. Vol. Price($)
0 41 $5.31
 

Sellers (Offers)

Price($) Vol. No.
$5.36 1938 0
Last trade - 05.14am 04/10/2024 (20 minute delay) ?
DGL (NZSX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
ASX Market Open: Middle East tensions push oil higher and Wall Street lower, reverberating on the ASX200 | October 4, 2024 Negative sentiment in US markets amid tensions in the Middle East have been felt on the Australian bourse, with the ASX200 opening lower
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
The Breakdown: Lithium Universe talks financial modelling and lithium pricing in strong preliminary feasibility study for Bécancour Lithium Universe Ltd is helping investors understand its recent prefeasibility study for a lithium plant in Quebec with a series of videos
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.

Featured News

AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS Boorara Gold Project hits first ore milestone—$30M in free cashflow forecast, find out what’s driving the success
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.